Antibody affinity birth through somatic hypermutation 2260015

N Natalie Caputo (Harvard Medical School) R Rahaman Ahmed (Brigham and Women’s Hospital) Z Zahra Allahyari (Brigham and Women’s Hospital) J Jessica Chen (1The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States) N Nicholas Garcia (Brigham and Women’s Hospital) A Avneesh Gautam (Brigham and Women’s Hospital) K Kenneth Green (Brigham and Women’s Hospital) J Joyce Hwang (Brigham and Women’s Hospital) S Sweta Khobragade (Brigham and Women’s Hospital) M Meydan Kronrod (Brigham and Women’s Hospital) S Sachin Kumar A Azadeh Mahdavinia (Brigham and Women’s Hospital) R Robert Novak (Brigham and Women’s Hospital) G Gaspar Pacheco (Brigham and Women’s Hospital, Harvard Medical School) V Vishal Rao S Shahab Saghaei (Brigham and Women’s Hospital) M Meghan Travers (Brigham and Women’s Hospital) D Duane Wesemann (Brigham and Women’s Hospital) M Mehrdad Zarghami (Jamaica Hospital, New York, New York, United States) T Teng Zuo (Brigham and Women’s Hospital)

Abstract

Abstract Introduction Developing B cells undergo V(D)J recombination, generating a B cell receptor (BCR) repertoire capable of recognizing diverse antigens (Ags). Upon BCR contact with cognate Ag, B cells enter the germinal center (GC) reaction and undergo somatic hypermutation (SHM). This leads to affinity maturation, a process by which the BCR acquires mutations that can increase affinity of the BCR for its cognate Ag, thus generating higher affinity antibodies. A traditional model of B cell activation requires BCR recognition of cognate Ag for initiation of SHM; however, evidence suggests this model may be incomplete. Multiple studies measuring the percentage of Ag+ GC B cells in response to immunization have described B cells in the mature GC with no measurable BCR recognition of immunizing Ag. In addition, some Abs generated against tumors and viral pathogens do not measurably bind Ag when reverted back to germline sequence. Here, we investigate whether non-cognate B cells participate in GC reactions and undergo SHM to gain specificity for non-cognate antigen. Methods We developed bone marrow chimeric mouse models with monoclonal B cell repertoires to pre-define non-cognate B cells prior to Ag exposure. We serially immunized these mice with a diverse panel of non-cognate Ags and used ELISAs, flow cytometry, and single-cell RNA-sequencing to track the mutational paths of these non-cognate BCRs. Results Pre-defined non-cognate B cells participated in GC reactions and underwent SHM in every mouse model and Ag tested. Phylogenetic analysis revealed diverse BCR mutational pathways resulting in de novo Ag recognition. Conclusion Our results expand upon a traditional model of B cell activation and reveal that specific BCR Ag recognition is not required for GC entry and initiation of SHM. In the absence of B cell competition, SHM can expand BCR Ag recognition beyond the primary repertoire, a phenomenon we term ‘affinity birth via SHM’. Current studies in the lab are exploring the role of CD4+ T cells in this phenomenon. Funding Source n/a Topic Categories Immune Response Regulation: Cellular Mechanisms (IRC)

Article Details

Volume / Issue Vol. 215, Issue Supplement_1
Published August 01, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (20)

N

Natalie Caputo

Harvard Medical School

R

Rahaman Ahmed

Brigham and Women’s Hospital

Z

Zahra Allahyari

Brigham and Women’s Hospital

J

Jessica Chen

1The University of Texas MD Anderson Cancer Center, Department of Lymphoma & Myeloma, Houston, United States

N

Nicholas Garcia

Brigham and Women’s Hospital

A

Avneesh Gautam

Brigham and Women’s Hospital

K

Kenneth Green

Brigham and Women’s Hospital

J

Joyce Hwang

Brigham and Women’s Hospital

S

Sweta Khobragade

Brigham and Women’s Hospital

M

Meydan Kronrod

Brigham and Women’s Hospital

S

Sachin Kumar

A

Azadeh Mahdavinia

Brigham and Women’s Hospital

R

Robert Novak

Brigham and Women’s Hospital

G

Gaspar Pacheco

Brigham and Women’s Hospital, Harvard Medical School

V

Vishal Rao

S

Shahab Saghaei

Brigham and Women’s Hospital

M

Meghan Travers

Brigham and Women’s Hospital

D

Duane Wesemann

Brigham and Women’s Hospital

M

Mehrdad Zarghami

Jamaica Hospital, New York, New York, United States

T

Teng Zuo

Brigham and Women’s Hospital